MinichMacGregor Wealth Management LLC Buys 23,337 Shares of First Trust Nasdaq Pharmaceuticals ETF $FTXH

MinichMacGregor Wealth Management LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 23,337 shares of the company’s stock, valued at approximately $968,000.

Several other hedge funds also recently added to or reduced their stakes in FTXH. Vivaldi Capital Management LP lifted its position in First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after buying an additional 1,741 shares during the last quarter. Nilsine Partners LLC boosted its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock worth $1,071,000 after buying an additional 937 shares during the period. Finally, Compass Financial Management LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the 2nd quarter valued at $29,000.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

Shares of NASDAQ FTXH traded up $0.85 during midday trading on Wednesday, hitting $41.28. The company’s stock had a trading volume of 20,488 shares, compared to its average volume of 233,446. The firm has a market capitalization of $1.07 billion, a price-to-earnings ratio of 14.51 and a beta of 0.45. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $28.85 and a 1 year high of $43.52. The business’s fifty day simple moving average is $41.07 and its two-hundred day simple moving average is $37.70.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Thursday, September 24th were paid a $0.0113 dividend. This is a decrease from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. This represents a $0.05 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Thursday, September 24th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.